Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)

被引：0

作者：

Kiyotaka Okuno

Toru Aoyama

Koji Oba

Noboru Yokoyama

Nobuhisa Matsuhashi

Katsuyuki Kunieda

Yoji Nishimura

Hiroki Akamatsu

Takaya Kobatake

Satoshi Morita

Takaki Yoshikawa

Junichi Sakamoto

Shigetoyo Saji

机构：

[1] Kindai University Faculty of Medicine,Department of Surgery

[2] Yokohama City University Yokoham,Department of Surgery

[3] The University of Tokyo,Department of Biostatistics

[4] Showa University Koto Toyosu Hospital,Digestive Disease Center

[5] Gifu University,Department of Surgical Oncology

[6] Gifu Prefectural General Medical Center,Department of Surgery

[7] Saitama Cancer Cancer,Department of Gastroenterological Surgery

[8] Osaka Police Hospital,Department of Surgery

[9] Shikoku Cancer Center Hospital,Department of Surgery

[10] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics

[11] Kanagawa Cancer Center,Department of Gastrointestinal Surgery

[12] Japanese Foundation for Multidisciplinary Treatment of Cancer,undefined

[13] Tokai Central Hospital,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2018年 / 81卷

关键词：

Rectal cancer; PSK; UFT, RFS, OS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：65 / 71

页数：6

共 50 条

[1] Randomized phase III trial comparing surgery alone to UFT plus PSK for stage II rectal cancer (JFMC38 trial)
Okuno, Kiyotaka
Aoyama, Toru
Oba, Koji
Yokoyama, Noboru
Matsuhashi, Nobuhisa
Kunieda, Katsuyuki
Nishimura, Yoji
Akamatsu, Hiroki
Kobatake, Takaya
Morita, Satoshi
Yoshikawa, Takaki
Sakamoto, Junichi
Saji, Shigetoyo
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 65 - 71
[2] Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG)
Yasuhiro Miyake
Junichi Nishimura
Takeshi Kato
Masataka Ikeda
Masaki Tsujie
Taishi Hata
Ichiro Takemasa
Tsunekazu Mizushima
Hirofumi Yamamoto
Mitsugu Sekimoto
Riichiro Nezu
Yuichiro Doki
Masaki Mori
Surgery Today, 2018, 48 : 66 - 72
[3] A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)
Oki, E.
Murata, A.
Yoshida, K.
Maeda, K.
Ikejiri, K.
Munemoto, Y.
Sasaki, K.
Matsuda, C.
Kotake, M.
Suenaga, T.
Matsuda, H.
Emi, Y.
Kakeji, Y.
Baba, H.
Hamada, C.
Saji, S.
Maehara, Y.
ANNALS OF ONCOLOGY, 2016, 27 (07) : 1266 - 1272
[4] A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Murata, Akihiko
Yoshida, Kazuhiro
Maeda, Kiyoshi
Ikejiri, Koji
Munemoto, Yoshinori
Sasaki, Kazuaki
Matsuda, Chu
Kotake, Masanori
Suenaga, Toyokuni
Matsuda, Hiroyuki
Baba, Hideo
Hamada, Chikuma
Oki, Eiji
Emi, Yasunori
Saji, Shigetoyo
Maehara, Yoshihiko
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Phase III trial comparing UFT plus PSK to UFT plus LV in stage IIB, III colorectal cancer (MCSGO-CCTG)
Miyake, Yasuhiro
Nishimura, Junichi
Kato, Takeshi
Ikeda, Masataka
Tsujie, Masaki
Hata, Taishi
Takemasa, Ichiro
Mizushima, Tsunekazu
Yamamoto, Hirofumi
Sekimoto, Mitsugu
Nezu, Riichiro
Doki, Yuichiro
Mori, Masaki
SURGERY TODAY, 2018, 48 (01) : 66 - 72
[6] A randomized phase III trial of 1-year adjuvant chemotherapy with oral tegafur-uracil (UFT) vs. surgery alone in stage II colon cancer: SACURA trial
Kajiwara, Yoshiki
Ishiguro, Megumi
Teramukai, Satoshi
Matsuda, Chu
Fujii, Shoichi
Kinugasa, Yusuke
Nakamoto, Yoshihiko
Kotake, Masanori
Sakamoto, Yoshiyuki
Kurachi, Kiyotaka
Maeda, Atsuyuki
Komori, Koji
Tomita, Naohiro
Shimada, Yasuhiro
Takahashi, Keiichi
Kotake, Kenjiro
Watanabe, Masahiko
Mochizuki, Hidetaka
Sugihara, Kenichi
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[7] Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
Ishiguro, Megumi
Mochizuki, Hidetaka
Tomita, Naohiro
Shimada, Yasuhiro
Takahashi, Keiichi
Kotake, Kenjiro
Watanabe, Masahiko
Kanemitsu, Yukihide
Ueno, Hideki
Ishikawa, Toshiaki
Uetake, Hiroyuki
Matsui, Shigeyuki
Teramukai, Satoshi
Sugihara, Kenichi
BMC CANCER, 2012, 12
[8] Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
Megumi Ishiguro
Hidetaka Mochizuki
Naohiro Tomita
Yasuhiro Shimada
Keiichi Takahashi
Kenjiro Kotake
Masahiko Watanabe
Yukihide Kanemitsu
Hideki Ueno
Toshiaki Ishikawa
Hiroyuki Uetake
Shigeyuki Matsui
Satoshi Teramukai
Kenichi Sugihara
BMC Cancer, 12
[9] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Sasako, Mitsuru
Sakuramoto, Shinichi
Katai, Hitoshi
Kinoshita, Taira
Furukawa, Hiroshi
Yamaguchi, Toshiharu
Nashimoto, Atsushi
Fujii, Masashi
Nakajima, Toshifusa
Ohashi, Yasuo
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4387 - 4393
[10] COLOR II - A randomized clinical trial comparing laparoscopic and open surgery for rectal cancer
Bonjer, H. J.
Cuesta, M. A.
Lacy, A. M.
Haglind, E.
Fuerst, A.
Lange, J. F.
Hop, W. C. J.
Buunen, M.
D'Hoore, A.
Inglis, K.
Jess, P.
Bulut, O.
Rosenberg, J.
Peiman
Christensen, M. Mark
Isalnieks, I.
Jaeger, C.
Kreis, M.
Jeekel, J.
van der Harst, E.
Coenen, P. P. L. O.
Gerhards, M. F.
Bemelman, W.
Jakimowicz, J. J.
van Riet, Y. E. A.
Hansson, B. M. E.
Rosman, C.
Neijenhuis, P. A.
den Outer, A. J.
Targarona, E. M.
Balague, C.
Delgado, S.
Lujan, J.
Garcia Molina, F. J.
Skullman, S.
Kurlberg, G.
Lackberg, Z.
Pahlman, L.
Kressner, U.
Matthiessen, P.
Kim, Seon-Hahn
DANISH MEDICAL BULLETIN, 2009, 56 (02) : 89 - 91

← 1 2 3 4 5 →